Pharmaron Beijing Co. Ltd (3759.HK) revealed a profit for nine months that Dropped, from last year
The company's earnings totaled RMB1.140 billion, or RMB0.6467 per share. This compares with RMB1.421 billion, or RMB0.8019 per share, last year.
The company's revenue for the period rose 14.4% to RMB10.085 billion from RMB8.817 billion last year.
Pharmaron Beijing Co. Ltd earnings at a glance (GAAP) :
-Earnings: RMB1.140 Bln. vs. RMB1.421 Bln. last year.-EPS: RMB0.6467 vs. RMB0.8019 last year.-Revenue: RMB10.085 Bln vs. RMB8.817 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.